{
    "clinical_study": {
        "@rank": "93973", 
        "arm_group": [
            {
                "arm_group_label": "Surgery"
            }, 
            {
                "arm_group_label": "Chemoradiation"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a two arm, single center feasibility study of 20 patients with non-metastatic\n      cervical cancer managed with surgery and/or chemoradiation therapy at UNC Hospitals.\n      Subjects will undergo PET/MRI scans before, during (chemoradiation group only), and after\n      treatment.\n\n      The primary purpose of this study is to evaluate the feasibility of obtaining complete and\n      interpretable hybrid PET/MR images for patients diagnosed with cervical cancer."
        }, 
        "brief_title": "Hybrid Pet/MR in the Therapy of Cervical Cancer", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cervix Carcinoma", 
            "Cervical Squamous Cell Carcinoma", 
            "Cervical Adenosquamous Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Squamous Cell", 
                "Uterine Cervical Neoplasms", 
                "Carcinoma, Adenosquamous"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265 18 years of age\n\n          -  Biopsy-proven, previously untreated squamous cell carcinoma, adenosquamous carcinoma,\n             or adenocarcinoma of the uterine cervix\n\n          -  Clinically visible lesion at least FIGO stage Ib or AJCC 7th edition T1b\n\n          -  Scheduled to undergo standard of care PET/CT for baseline assessment of disease\n\n          -  Anticipated to be eligible for curative intent therapy (surgery of chemoradiation\n             therapy) as determined by the patient's primary oncologist\n\n          -  If female of child-bearing potential, negative serum or urine pregnancy test \u2264 7 dats\n             prior to first PET/MRI\n\n          -  Informed consent reviewed and signed\n\n        Exclusion Criteria:\n\n          -  History of sever reaction to contrast-enhanced CT scan\n\n          -  Inability to tolerate MRI (e.g., inability to lie flat > 1 hour)\n\n          -  Presence of pacemaker, intracranial aneurysm clip, bladder stimulator, cochlear\n             implant or metal near eyes\n\n          -  Poorly controlled diabetes mellitus\n\n          -  Creatinine > 1.4 mg/dL or GFR < 30 mL/min\n\n          -  Body Mass Index (BMI) > 35\n\n          -  Active vaginal bleeding requiring packing and emergent radiation therapy\n\n          -  Pregnant or lactating female\n\n          -  History of a prior malignancy within past 5 years, unless disease free for \u2265 3 years\n\n          -  Substance abuse, medical, psychological, or social conditions that may interfere with\n             study participation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "UNC Hospitals"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759355", 
            "org_study_id": "LCCC1221"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2013", 
        "location": {
            "contact": {
                "email": "riguera@email.unc.edu", 
                "last_name": "Dorothy Riguera, BS", 
                "phone": "919-843-5420"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "University of North Carolina-Chapel Hill"
            }, 
            "investigator": [
                {
                    "last_name": "Julia Fielding, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ellen Jones, MD,PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Paola Gehrig, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Victoria Bae-Jump, MD,PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Mahesh Varia, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Amir Khandani, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "William McCartney, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Nathan Sheets, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Hybrid PET/MR in the Therapy of Cervical Cancer: A Pilot Study", 
        "overall_contact": {
            "email": "riguera@email.unc.edu", 
            "last_name": "Dorothy Riguera, BS", 
            "phone": "919-843-5420"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Julia Fielding, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Data and Safety Monitoring Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Proportion of patients who successfully complete PET/MR scans at all study time-points", 
            "safety_issue": "No", 
            "time_frame": "2-3 months post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759355"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Estimated proportion of subjects with disease (positive pathology or PET/CT) that have positive PET/MR scans.", 
                "measure": "Sensitivity of PET/MR for baseline disease assessment", 
                "safety_issue": "No", 
                "time_frame": "pre-treatment"
            }, 
            {
                "description": "Proportion of subjects without disease (negative pathology or PET/CT) that have negative PET/MR scans.", 
                "measure": "Specificity of hybrid PET/MR  for baseline disease assessment", 
                "safety_issue": "No", 
                "time_frame": "pre-treatment"
            }, 
            {
                "description": "Proportion of correct assessments among total population", 
                "measure": "Accuracy of hybrid PET/MR for baseline disease assessment", 
                "safety_issue": "No", 
                "time_frame": "pre-treatment"
            }, 
            {
                "measure": "Detection of disease with PET/MR at each time point", 
                "safety_issue": "No", 
                "time_frame": "pre-treatment to 2-3 months post-treatment"
            }
        ], 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}